Overview

Alpha-lipoic Acid in Diabetic Nephropathy

Status:
RECRUITING

Trial end date:
2024-02-01

Target enrollment:

Participant gender:

Summary

Endothelial dysfunction in diabetes is a central event in the pathogenesis of different microangioapthic changes. Nephropathy in patients with type 1 diabetes is a severe microvascular complication.

Phase:

PHASE3

Details

Lead Sponsor:

Ain Shams University

Treatments:

Captopril
Tablets
Thioctic Acid